Search Results
Sep 03, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors - AARD
clinical studies under the IND, including the Phase 3 HERO trial (AVK-101-301) evaluating ARD-101 for the treatment of hyperphagia in patients with Prader-Willi Syndrome (PWS) and the Phase 3 open-label extension (OLE) trial (AVK-101-302)." On this news, Aardvark's stock price fell $2.16 per share,
More news about: Pomerantz LLP
Aug 28, 2026, 17:42 ET Robbins LLP Urges AARD Stockholders Who Lost Money Investing in Aardvark Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action
clinical studies under the IND, including the Phase 3 HERO trial (AVK-101-301) evaluating ARD-101 for the treatment of hyperphagia in patients with Prader-Willi Syndrome (PWS) and the Phase 3 open-label extension (OLE) trial (AVK-101-302)." On this news, Aardvark's stock price fell $2.16 per share, or 32.1%,
More news about: Robbins LLP
Aug 27, 2026, 16:04 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors - AARD
clinical studies under the IND, including the Phase 3 HERO trial (AVK-101-301) evaluating ARD-101 for the treatment of hyperphagia in patients with Prader-Willi Syndrome (PWS) and the Phase 3 open-label extension (OLE) trial (AVK-101-302)." On this news, Aardvark's stock price fell $2.16 per share,
More news about: Pomerantz LLP
Aug 20, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors - AARD
clinical studies under the IND, including the Phase 3 HERO trial (AVK-101-301) evaluating ARD-101 for the treatment of hyperphagia in patients with Prader-Willi Syndrome (PWS) and the Phase 3 open-label extension (OLE) trial (AVK-101-302)." On this news, Aardvark's stock price fell $2.16 per share,
More news about: Pomerantz LLP
Aug 17, 2026, 16:56 ET AARD Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Aardvark Therapeutics, Inc.
clinical studies under the IND, including the Phase 3 HERO trial (AVK-101-301) evaluating ARD-101 for the treatment of hyperphagia in patients with Prader-Willi Syndrome (PWS) and the Phase 3 open-label extension (OLE) trial (AVK-101-302)." On this news, Aardvark's stock price fell $2.16 per share, or 32.1%,
More news about: Robbins LLP
Jun 11, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aardvark Therapeutics, Inc. - AARD
clinical studies under the IND, including the Phase 3 HERO trial (AVK-101-301) evaluating ARD-101 for the treatment of hyperphagia in patients with Prader-Willi Syndrome (PWS) and the Phase 3 open-label extension (OLE) trial (AVK-101-302)." On this news, Aardvark's stock price fell $2.16 per share,
More news about: Pomerantz LLP
May 28, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aardvark Therapeutics, Inc. - AARD
clinical studies under the IND, including the Phase 3 HERO trial (AVK-101-301) evaluating ARD-101 for the treatment of hyperphagia in patients with Prader-Willi Syndrome (PWS) and the Phase 3 open-label extension (OLE) trial (AVK-101-302)." On this news, Aardvark's stock price fell $2.16 per share,
More news about: Pomerantz LLP
May 21, 2026, 18:40 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aardvark Therapeutics, Inc. - AARD
clinical studies under the IND, including the Phase 3 HERO trial (AVK-101-301) evaluating ARD-101 for the treatment of hyperphagia in patients with Prader-Willi Syndrome (PWS) and the Phase 3 open-label extension (OLE) trial (AVK-101-302)." On this news, Aardvark's stock price fell $2.16 per share,
More news about: Pomerantz LLP
Mar 23, 2026, 06:01 ET Data Center Liquid Cooling Valves Market worth $1.80 billion by 2032 - Exclusive Report by MarketsandMarkets™
identified as some of the leading players in the data center liquid cooling valves market, given their strong market share and product footprint.AVK Holding A/S and FlowCon International, among others, have become leading startups or SMEs by identifying niche gaps early and delivering solutions that
More news about: MarketsandMarkets
Mar 16, 2026, 08:00 ET Pure DC and AVK Deploy Europe's First Data Centre Microgrid
www.puredc.com About AVKAVK is the largest and fastest-growing supplier of innovative power solutions for data centres and leading UK and European organisations. We specialise in all aspects of design, planning, implementation, and continuing maintenance.At AVK, we power tomorrow's data.
More news about: Pure DC
Mar 16, 2026, 04:00 ET Pure DC und AVK setzen Europas erstes Mikronetz für Rechenzentren ein
Pure DC finden Sie auf www.puredc.com. Informationen zu AVKAVK ist der größte und am schnellsten wachsende Anbieter innovativer Stromversorgungslösungen für Rechenzentren sowie für führende Organisationen
More news about: Pure DC
Mar 16, 2026, 04:00 ET Pure DC and AVK Deploy Europe's First Data Centre Microgrid
www.puredc.com About AVKAVK is the largest and fastest-growing supplier of innovative power solutions for data centres and leading UK and European organisations. We specialise in all aspects of design, planning, implementation, and continuing maintenance.At AVK, we power tomorrow's data.
More news about: Pure DC
Mar 16, 2026, 04:00 ET Pure DC y AVK ponen en marcha la primera microrred de centros de datos de Europa
más información sobre Pure DC, visite www.puredc.com Acerca de AVK AVK es el mayor proveedor, y el de más rápido crecimiento, de soluciones energéticas innovadoras para centros de datos y organizaciones líderes de
More news about: Pure DC
Mar 16, 2026, 04:00 ET Pure DC et AVK déploient le premier micro-réseau de centre de données en Europe
Europe, AVK dispose d'un avantage unique en termes d'échelle opérationnelle et de capacités de livraison pour prendre en charge des projets d'ingénierie et d'énergie complexes, à grande échelle et révolutionnaires.AVK - Alimenter
More news about: Pure DC